BLU-V
LIVE

Serial Number

79139362

Owner

QIAGEN GMBH

Attorney

Lorraine Linford

Filing Date

Aug 6, 2013

Add to watchlist:

No watchlists yet
View on USPTO

BLU-V Trademark

Serial Number: 79139362 • Registration: 4622998

BLU-V is a trademark filed by QIAGEN GMBH on August 6, 2013. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). The application is currently registered and active.

Owner Contact Info

QIAGEN GMBH (211 trademarks)

HILDEN D-4010 , DE

Entity Type: 03

Trademark Details

Filing Date

August 6, 2013

Registration Date

October 21, 2014

Published for Opposition

August 5, 2014

Cancellation Date

August 5, 2023

Goods & Services

Scientific apparatus, instruments and equipment, namely, test tubes, laboratory vessels, columns for laboratory use, laboratory sample holders, laboratory boxes for incubation of biological or biochemical samples, and devices for light exposure of biological or biochemical samples for research and analysis purposes, and laboratory apparatus, measuring apparatus and instruments for use with products for human medical and veterinary medical diagnostic purposes, for sample preparation, modification and manipulation of cells, labeling, separation, identification, quantification, isolation, purification, amplification or analysis of biopolymers, and for detection of contaminating biomolecules, in the nature of nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids from biological or biochemical sample material

Diagnostic preparations for medical or veterinary purposes; diagnostic preparations for medical and veterinary use, in particular for sample preparation, the modification and manipulation of cells, the labeling, separation, identification, quantification, isolation, purification, amplification and analysis of biopolymers, in the nature of nucleic acids, proteins, macromolecules and biologically active substances; chemical, biochemical and biotechnological products, namely, reagents and solvents for medical and veterinary use for sample preparation, the modification and manipulation of cells, the labeling, separating, identifying, quantifying, isolating, purifying, amplifying or analyzing of biopolymers, and for detection of contaminating biomolecules, in the nature of nucleic acids, proteins, macromolecules and biologically active substances for diagnostic purposes; kits containing preparations for human medical and veterinary diagnostic purposes, in particular for sample preparation, the modification and manipulation of cells, the labeling, separation, identification, quantification, isolation, purification, amplification and analysis of biopolymers, and for detection of contaminating biomolecules in the nature of nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids from biological or biochemical sample material

Chemicals for industrial and scientific purposes; biochemical and biotechnological products for industrial and scientific purposes, namely, reagents and solvents for sample preparation, the modification and manipulation of cells, the labeling, separating, identifying, quantifying, isolating, purifying, amplifying or analyzing of biopolymers, in the nature of nucleic acids, proteins, macromolecules and biologically active substances, and for detection of contaminating biomolecules; kits for laboratory or research use comprising chemicals for sample preparation, the modification and manipulation of cells, the labeling, separation, identification, quantification, isolation, purification, amplification and analysis of biopolymers, and for detection of contaminating biomolecules, in the nature of nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids from biological or biochemical sample material

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Mar 3, 2024 DENC
DEATH OF INTERNATIONAL REGISTRATION
Mar 3, 2024 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Jul 11, 2022 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
May 5, 2022 INTS
INVALIDATION PROCESSED
May 5, 2022 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 7, 2022 INTR
CANCELLED SECTION 71
May 7, 2021 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 21, 2019 REM3
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 7, 2019 TCCA
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 3, 2015 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 19, 2015 FICS
FINAL DISPOSITION PROCESSED
Mar 19, 2015 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 21, 2015 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 21, 2014 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 5, 2014 NPUB
PUBLISHED FOR OPPOSITION
Aug 5, 2014 PUBO
NOTIFICATION PROCESSED BY IB
Aug 1, 2014 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 16, 2014 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 16, 2014 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 16, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 30, 2014 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 24, 2014 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 24, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 24, 2014 CRFA
ASSIGNED TO LIE
Jun 18, 2014 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 10, 2014 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Apr 17, 2014 NREP
REFUSAL PROCESSED BY IB
Dec 31, 2013 RFNT
APPLICATION FILING RECEIPT MAILED
Dec 13, 2013 MAFR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 12, 2013 RFCS
REFUSAL PROCESSED BY MPU
Dec 12, 2013 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 11, 2013 RFCR
NON-FINAL ACTION WRITTEN
Dec 10, 2013 CNRT
ASSIGNED TO EXAMINER
Dec 9, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 9, 2013 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 6, 2013 REPR